Podcast
Health Innovation North West Coast
Hosted by Health Innovation North West Coast · EN
Innovators and influencers who help to improve health and care feature in the Health Innovation North West Coast podcast.
Most guests are from around the North West Coast - Cheshire, Merseyside, Lancashire and South Cumbria - along with colleagues from around the country, sharing their stories and inspiring our listeners.
Most guests are from around the North West Coast - Cheshire, Merseyside, Lancashire and South Cumbria - along with colleagues from around the country, sharing their stories and inspiring our listeners.
10episodes
Episodes
Newest firstAll episodes
S21 Ep49: The future of primary care in Cheshire and Merseyside
Dec 15, 202300:39:55Tap to summarizeThe way primary care services are delivered is changing, with different specialists on hand via GP practices and with a growing number of diagnostic tests, screening and treatments available in community pharmacies. We explore what’s in store for primary care in Cheshire and Merseyside after the launch of a new strategic framework which offers a timeline of actions at both local and system level. Dr Jonathan Griffiths, Associate Medical Director for Primary Care at NHS Cheshire and Merseyside, and Adam Irvine, Primary Care Partner Member (Pharmacy) at NHS Cheshire and Merseyside, are in conversation with Dr Phil Jennings, Chief Executive of Health Innovation North West Coast. Greg Stringer introduces the conversation. Useful links: The first two chapters of the Primary Care Strategic Framework are here: https://www.cheshireandmerseyside.nhs.uk/about/cheshire-and-merseyside-health-and-care-partnership/ The NHS Primary Care Access Recovery Plan is here: https://www.england.nhs.uk/publication/delivery-plan-for-recovering-access-to-primary-care/ Find out more about the Pharmacy First service: https://cpe.org.uk/national-pharmacy-services/advanced-services/pharmacy-first-service/
Transcribe →
S21 Ep48: Improving urgent care for cancer patients
Oct 5, 202300:31:59Tap to summarizeFor anyone involved in an emergency or needing urgent treatment, the experience can be scary and prolonged. For those who have cancer, the prospect is far more daunting. In Cheshire and Merseyside, health leaders have collaborated to create pathways and processes which ensure that cancer patients can avoid visits to A&E and potentially long stays in hospital awaiting decisions and treatment. We hear how they created a model which is now being held up as an exemplar nationally. Caroline Kenyon is in conversation with Dr Ernie Marshall, consultant medical oncologist at The Clatterbridge Cancer Centre NHS Foundation Trust; Dr Ragit Varia, acute medical lead for the urgent cancer care programme based at Mersey and West Lancashire Teaching Hospitals NHS Trust; and Mel Warwick, programme lead. Useful links NHS Providers case study: https://nhsproviders.org/providers-deliver-trusts-in-systems/the-clatterbridge-cancer-centre-nhs-foundation-trust The Clatterbridge Cancer Centre NHS Foundation Trust: https://www.clatterbridgecc.nhs.uk/
Transcribe →
S21 Ep47: An academic activist – Gideon Ben-Tovim OBE
Jul 24, 202300:33:08Tap to summarizeGideon Ben-Tovim OBE talks about the passions and experiences which have shaped his leadership, as he prepares to step down after ten years as Chair of the Innovation Agency. A former researcher and author on race relations; Liverpool City Council Labour leader; chair of Liverpool Primary Care Trust; and champion of the natural environment, Gideon recalls pivotal moments in his career – and in the history of his home city. CLANG: Connect, keep Learning, Be Active, Take Notice and Give – devised by Gideon Ben-Tovim OBE.
Transcribe →
S21 Ep46: Transforming diagnostics – ‘the first piece in the jigsaw’
Jun 30, 202300:25:16Tap to summarizeChanges to the way diagnostic tests and screening are carried out in Cheshire and Merseyside mean many more tests are being carried out in more centres around the region. A system-wide transformation programme has streamlined processes and introduced a new, flexible staffing system, while improving access to tests for patients. Guests Liz Bishop and Dr Ash Bassi explain how the transformation is being carried out, in conversation with Caroline Kenyon. Liz is Chief Executive of The Clatterbridge Cancer Centre NHS Foundation Trust and lead for the Cheshire and Merseyside Diagnostic Transformation Programme; and Senior Responsible Officer for Cancer in Cheshire and Merseyside. Ash is a consultant gastroenterologist at St Helens and Knowsley NHS Foundation Trust; Clinical Lead for the Cheshire and Merseyside Endoscopy Network; and North West Transformation Lead for Endoscopy. Diagnostics - NHS Cheshire and Merseyside Cheshire and Merseyside leading the way to improved diagnostic testing - NHS Cheshire and Merseyside
Transcribe →
S21 Ep45: New ERA for maternity safety
Jun 6, 202300:25:28Tap to summarizeAn entrepreneurial doctor whose company is backed by the Innovation Agency, has become an Innovation Fellow with the NHS Innovation Accelerator. Dr Michael Watts has helped to create a patient-centred, emergency-support software system designed to improve safety in maternity - Emergency Role Allocation (ERA). ERA was the brainchild of midwife Caroline Lacey, of Somerset NHS Foundation Trust. Michael is one of 17 new Innovation Fellows, selected to help spread cutting-edge solutions with the potential to transform healthcare. In this podcast, Michael and Caroline tell us how the innovation came about – and the potential for the system to improve the safety of patients in a range of settings. News story: https://www.innovationagencynwc.nhs.uk/news/Medic-backed-by-Innovation-Agency-joins-NHS-innovation-accelerator NHS Innovation Accelerator: https://www.england.nhs.uk/aac/ Blum Health: https://blumtechgroup.com/ NHS Clinical Entrepreneur Programme: https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/clinical-entrepreneur-programme
Transcribe →
S21 Ep44: CVD innovations in primary care
May 2, 202300:37:54Tap to summarizeThis episode explores innovations in cardiovascular disease management being delivered to patients in primary care. In particular, the conversation focusses on lipids management and the introduction of a new treatment pathway which includes novel therapies. Innovation Agency chief executive Dr Phil Jennings talks to Dr Jim Moore, GP and president of the Primary Care Cardiovascular Society. To find out more about the Innovation Agency’s work in CVD, visit: https://www.innovationagencynwc.nhs.uk/lipids-and-cholesterol-management Visit the Primary Care Cardiovascular Society website: www.pccsuk.org The Innovation Agency is part of the AHSN Network: https://www.ahsnnetwork.com/
Transcribe →
S21 Ep43: Using data to reduce health inequalities in Cheshire and Merseyside
Mar 28, 202300:13:42Tap to summarizeThe Innovation Agency is working with NHS Cheshire and Merseyside to help people at increased risk because of the combination of suffering a respiratory or cardiovascular condition and living in a cold home. It’s part of NHS England’s Innovation for Healthcare Inequalities Programme (InHIP) which seeks to address local healthcare inequalities experienced by deprived and other under-served populations. We hear from Professor Rowan Pritchard-Jones, Executive Medical Director of NHS Cheshire and Merseyside, about how joining up data from different systems can enable health professionals to pinpoint individuals at increased need of help. If you are interested in finding out more, please email Rhiannon.Clarke@innovationagencynwc.nhs.uk or info@innovationagencynwc.nhs.uk.
Transcribe →
S21 Ep42: New service to identify killer gene
Mar 24, 202300:34:04Tap to summarizeThe family of a 29 year old Cheshire man who died suddenly from heart failure have been diagnosed with a genetic condition which causes abnormally high levels of cholesterol. The condition is familial hypercholesterolaemia, or FH; and the family of the late Mike Clarke have now been tested for FH at a new screening service for Cheshire and Merseyside. In this podcast we hear from Mike’s brother Simon and three people behind the new testing service, clinical lead Consultant Chemical Pathologist Dr Shirley Bowles; Consultant Chemical Pathologist Dr David Oleesky; and FH service specialist nurse Julia Finch. They’re in conversation with Caroline Kenyon. A fundraising page has been set up by Katie Bridge, Mike Clarke’s sister, in aid of Cardiac Risk in the Young: https://www.justgiving.com/fundraising/katie-bridges2 Find out more about the Innovation Agency's work on lipids and cholesterol management on the website: https://www.innovationagencynwc.nhs.uk/lipids-and-cholesterol-management
Transcribe →
S21 Ep41: Cardiovascular disease prevention in the North West Coast
Feb 9, 202300:15:45Tap to summarizeA significant number of people across the North West Coast are unaware that they have high blood pressure. And during the pandemic, the British Heart Foundation reported that nearly half a million people in the UK missed out on starting medication to help prevent heart attacks and strokes. In this podcast, Dr Andy Knox, a GP in Lancashire and Cumbria who is also the area's associate medical director for population health; and the Innovation Agency's CVD prevention programme lead Dr Julia Reynolds tell Nigel Thompson how they hope to turn the tide by identifying more people with high blood pressure - many of whom are blissfully unaware they may have it.
Transcribe →
S21 Ep40: Liverpool Severe Asthma Service
Feb 7, 202300:16:24Tap to summarizeAsthma presents a continuing challenge across primary care and research has shown that despite best efforts the numbers of patients who require optimisation and access to advanced therapies remains high. The Liverpool Severe Asthma Service (LSAS), which covers Cheshire and Merseyside, has been accelerating access to specialist care for asthma patients through innovative pathway transformation work. A campaign is now underway to encourage early referral to specialist asthma services, for patients at risk of having severe asthma. In this podcast, we hear from asthma specialists and a patient about the impact of the transformed pathway.
Transcribe →